These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3135970)

  • 1. [The effective of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in hypersomnia and subcortical dementia caused by bilateral medial thalamic and midbrain infarcts].
    Komiya T; Narabayashi H; Kondo T
    Rinsho Shinkeigaku; 1988 Mar; 28(3):268-71. PubMed ID: 3135970
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case with bilateral thalamic and midbrain infarction showing prolonged somnolence and various symptoms resembling those of progressive supranuclear palsy].
    Hashimoto T; Kondo K; Oguchi M; Yanagisawa N
    Rinsho Shinkeigaku; 1986 Jul; 26(7):713-6. PubMed ID: 3769320
    [No Abstract]   [Full Text] [Related]  

  • 3. [D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia].
    Kondo T
    Rinsho Shinkeigaku; 1984 Mar; 24(3):280-8. PubMed ID: 6432393
    [No Abstract]   [Full Text] [Related]  

  • 4. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
    Ogawa N; Yamamoto M; Takayama H
    J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thalamic dementia secondary to acute bilateral paramedian thalamic infarcts after occlusion of the artery of Percheron].
    García-Casares N; Garzón-Maldonado FJ; de la Cruz-Cosme C
    Rev Neurol; 2008 Feb 16-29; 46(4):210-2. PubMed ID: 18327742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of L-threo-DOPS on P-300 in parkinsonism].
    Yokota J; Itoh T; Imai H; Narabayashi H
    Rinsho Shinkeigaku; 1990 May; 30(5):499-504. PubMed ID: 2119267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dementia secondary to thalamic infarct: a case report].
    Cargioli Vila MV; Carriquiry Berner F; Vargas Cañas A
    Rev Neurol; 2004 Mar 1-15; 38(5):443-5. PubMed ID: 15029523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paramedian thalamic and midbrain infarcts associated with palilalia].
    Yasuda Y; Akiguchi I; Ino M; Nabatabe H; Kameyama M
    Rinsho Shinkeigaku; 1989 Feb; 29(2):186-90. PubMed ID: 2752646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism.
    Narabayashi H; Kondo T; Nagatsu T; Hayashi A; Suzuki T
    Adv Neurol; 1984; 40():497-502. PubMed ID: 6421112
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolated hypersomnia due to bilateral thalamic infarcts.
    Goyal MK; Kumar G; Sahota PK
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):146-7. PubMed ID: 20851635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral paramedian thalamic infarcts.
    Giannopoulos S; Kostadima V; Selvi A; Nicolopoulos P; Kyritsis AP
    Arch Neurol; 2006 Nov; 63(11):1652. PubMed ID: 17101838
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
    Ogawa N; Kuroda H; Yamamoto M; Nukina I; Ota Z
    Acta Med Okayama; 1984 Jun; 38(3):301-4. PubMed ID: 6431755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramedian thalamic and midbrain infarcts associated with palilalia.
    Yasuda Y; Akiguchi I; Ino M; Nabatabe H; Kameyama M
    J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):797-9. PubMed ID: 2246662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral paramedian thalamic and mesencephalic infarcts in a newborn due to occlusion of the artery of Percheron.
    Bain SE; Hsieh DT; Vezina LG; Chang T
    J Child Neurol; 2009 Feb; 24(2):219-23. PubMed ID: 19182161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
    Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
    Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
    Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.